262 million patients treated

We follow a patient-centric approach that prioritises accessibility and aligns with evolving disease burdens and patient needs.

Our state-of-the-art facilities span MENA, the United States, and Europe, creating a comprehensive global network that delivers high-quality medicines to patients worldwide.

As we continue expanding our manufacturing capacity, we're strengthening our ability to supply essential medicines to more patients.

We collaborate with partners to bring in-licensed patented products to our markets and provide specialised contract manufacturing services. Through targeted partnerships with industry associations and sector-specific organisations, we're working to improve generic medicine availability and ensure patients have access to the treatments they need. Our collaborative approach means better outcomes for patients.